Unless you're part of the official trial, you cannot legally access this medication in the UK
To learn more and schedule a consultation, call us at 425-775-3561
AWARD-6 is a randomized, open, parallel-grouped, multicenter, phase 3, non-inferiority study comparing the safety and efficacy of weekly DUL and daily LIR in patients with uncontrolled T2DM treated with metformin
In Phase 2 trials, participants on higher doses experienced average weight losses of more than 20% of body weight over 48 weeks, with a high proportion achieving large reductions in weight
| Grns
For Canadians who want to avoid the uncertainty of international shipping and customs processing, a domestic supplier eliminates those variables entirely